PreveCeutical Medical Inc (18H) — Cash Flow Reinvestment Rate

Latest as of September 2021: 0.00x

PreveCeutical Medical Inc (18H) has a Cash Flow Reinvestment Rate of 0.00x as of September 2021, reinvesting €0.00 (capex €0.00 ) from operating cash flow of €231.85K. Check PreveCeutical Medical Inc (18H) cash flow quality to evaluate the quality of earnings relative to operating cash generation.

Reinvestment Rate

0.00x

(Capex + Investments) / Operating CF

Total Reinvested

€0.00

Capex + Investments

Operating Cash Flow

€231.85K

EUR

Capital Expenditures

€0.00

EUR

PreveCeutical Medical Inc Cash Flow Reinvestment Rate (2020–2020)

Historical reinvestment intensity for PreveCeutical Medical Inc across 1 annual periods. Explore debt repayment capacity of PreveCeutical Medical Inc to assess how comfortably operating cash covers total debt obligations.

Annual Cash Flow Reinvestment Rate for PreveCeutical Medical Inc (2020–2020)

Year-by-year capital reinvestment analysis for PreveCeutical Medical Inc. For live market cap and broader valuation context, see market value of PreveCeutical Medical Inc.

Year	Reinvestment Rate	Total Reinvested (EUR)	Operating CF	Capex	YoY Change
2020	0.08x	€5.30K	€64.59K	€2.65K	—

Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow